In order to investigate the impact of DKK1 on bone metabolism in OI mice, a protocol entailing the administration of either DKK1-AS or DKK1-S was instituted for four weeks in the ensuing experiments. The gene discussed is DKK1; the disease is osteogenesis imperfecta.